StradosPortfolio

cultivate(MD) portfolio company Strados Labs, the respiratory endpoint intelligence company, announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) — complementing its existing technologies for cough monitoring and […]

Strados Labs, a cultivate(MD) portfolio company announced a new collaboration with Beth Israel Deaconess Medical Center (BIDMC). The upcoming study will evaluate the use of Strados Labs’ RESP® Biosensor, an FDA-cleared wearable stethoscope technology, for the early detection of pulmonary edema in critically ill patients on mechanical ventilation (MV). This pilot study is scheduled to

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced its pre-series A round of funding at $4.5M. Investors in the round included SOSV, cultivate(MD), Wavemaker360 Health, Blu Venture Investors and Broad Street Angels.